AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mosley, E. E
Right arrow Articles by McGuire, M. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mosley, E. E
Right arrow Articles by McGuire, M. A
Agricola
Right arrow Articles by Mosley, E. E
Right arrow Articles by McGuire, M. A
American Journal of Clinical Nutrition, Vol. 82, No. 6, 1292-1297, December 2005
© 2005 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

trans Fatty acids in milk produced by women in the United States1,2,3

Erin E Mosley, Anne L Wright, Michelle K McGuire and Mark A McGuire

1 From the Department of Animal and Veterinary Science, University of Idaho, Moscow, ID (EEM and MAM); the Arizona Respiratory Center, University of Arizona, Tucson, AZ (ALW); and the Department of Food Science and Human Nutrition, Washington State University, Pullman, WA (MKM)

2 Supported by the United Dairymen of Idaho, the Idaho Agricultural Experiment Station, Washington State University Agricultural Research Center, and grant no. AI42268 from the National Institutes of Health.

3 Reprints not available. Address correspondence to MA McGuire, University of Idaho, PO Box 442330, Moscow, ID 83844-2330. E-mail: mmcguire{at}uidaho.edu.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background:trans Fatty acids (FAs) have been identified as negatively affecting human health. The trans FA composition of human milk fat must be examined to establish its influence on the nutritional quality of milk consumed by infants.

Objective: We sought to ascertain the individual and total trans FA isomers (sum of FAs containing at least one trans double bond) in human milk and to identify relations between individual FAs and milk fat concentration (% by wt).

Design: The FA composition of milk samples (n = 81) from women living in the southwestern United States was ascertained. The individual 18:1t isomers were separated. Correlations between each FA, total trans FAs, groups of similar FAs, and milk fat concentrations were examined.

Results: The mean total trans FA concentration was 7.0 ± 2.3% (range: 2.5–13.8%). The concentration of total 18:1t was 5.1 ± 2.0% (range: 1.5–11.6%), and {Delta}10t (range: {Delta}9–12t) was the most abundant isomer.

Conclusions: Milk fat from women living in the United States contains concentrations of trans FAs similar to those in milk from Canadian women but greater than those reported in milk from women in other countries. In decreasing order of concentration, the {Delta}10t, {Delta}11t, {Delta}9t, and {Delta}12t isomers represented 78.9% of the total 18:1t. These FAs generally originate from partially hydrogenated vegetable oils and ruminant fat in the diet. No relation was found between the concentration of total trans FAs and milk fat concentration.

Key Words: Milk fat • trans fatty acids • human milk • lipids • lactation • US women


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Human milk is considered to be the gold standard for nourishing infants. Mature milk generally contains from 3.5% to 4.5% lipid, mostly triacylglycerols (1). Milk fatty acids (FAs) are either synthesized in the mammary gland or are derived from plasma FAs that originate from the diet, synthesis in nonmammary tissues, or lipid stores (2). It is well established that the FA composition of the diet can alter milk FA composition (3).

trans FAs are defined as those that contain at least one double bond in the trans configuration. They are formed during the chemical hydrogenation of vegetable oils to manufacture commercial fats or during the microbial biohydrogenation of FAs in the digestive tract of ruminant animals. The consumption of trans FA–containing foods by lactating women results in the incorporation of trans FAs in their milk fat (3-5).

Some of the trans FAs found in human milk fat have been identified as having potentially negative effects on human health, primarily via altering lipid metabolism. For example, the consumption of some trans FAs is associated with higher total and LDL-cholesterol concentrations and lower HDL-cholesterol concentrations in humans (6). This increase in the ratio of LDL to HDL cholesterol has been associated with a higher risk of coronary artery disease (7). Furthermore, trans FAs have been implicated in the impairment of essential FA metabolism through their inhibition of the synthesis of long-chain polyunsaturated FAs (PUFAs) in humans and animals (8). This inhibition might result in a negative effect on infant growth (9, 10). Finally, trans FAs have also been implicated in a decrease in milk fat in humans (11), mice (12), and cattle (13). Specifically, the trans FA 18:2{Delta}10t12c, an isomer of conjugated linoleic acid (CLA), has been identified as causing a decrease in fat in the milk of cattle (14). Similarly, women consuming a 1.5-g CLA supplement containing {approx}37% of the 18:2{Delta}10t12c isomer experienced a decrease in milk fat (11). The decrease in milk fat content would result in lower energy density of human milk.

Because of the potential negative effects of trans FAs, the Institute of Medicine has indicated that the intake of trans FA should be "as low as possible" (15). In addition, the Food and Drug Administration ruled that the trans FA content of foods must be included on nutrition labels (16). Even before these labeling laws, concern about the safety of trans FAs resulted in the documentation of their concentration in human milk fat. There have been several studies of the trans FA content of milk from women (17-26), but few analyzed the isomers of 18:1t. The main objective of the current study was to ascertain the isomeric and total trans FA concentrations (sum of all FAs that contain ≥1 trans double bond) of milk produced by US women. We hypothesize that total trans FAs will be inversely related to total milk fat content. To identify possible interactions between milk fat synthesis and specific FAs, we also examined correlations between each FA, total trans FA concentration, and milk fat concentration (% by wt).


   SUBJECTS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
Healthy women between 32–35 wk gestation who planned to obtain care for their newborns through pediatric practices (which participated in identifying subjects and assisting in the original study) were eligible to participate in the study. The study population was 73.3% non-Hispanic white, and 78.5% of the participants had some college education; more details were provided in Oddy et al (27). All women were consuming self-selected diets. Because the parent study did not initially aim to examine the effect of maternal diet on milk composition, documentation of dietary intake was not part of the experimental design of the current study.

Written informed consent was obtained from all participants. The parent protocol and the protocol for the current study were approved by the University of Arizona Institutional Review Board.

Methods
The samples utilized in this study were collected as a part of the larger Infant Immune Study, which was designed to investigate immune system markers of asthma risk in infancy and early childhood (27). Milk samples were obtained during the period from November 1996 to March 2002 by complete expression of breast milk of women (n = 81) during the first month (x ± SD: 11.2 ± 5.8 d) after delivery. The entire contents of one breast were collected by using a low-pressure electric breast pump (LACT-E; Ameda-Engell Corp, Cary, IL). Milk samples were collected within 2 h after the first feeding of the day, which was defined as a feeding occurring between 0600 and 0800. Milk fat concentration was measured in a subset of samples (n = 65) by using the creamatocrit method (28). After their collection, milk samples were maintained at room temperature until they were processed. Within 4 h of collection, milk was centrifuged at 500 x g for 12 min at room temperature, and the lipid layer was removed and frozen at –20 °C. Milk lipid samples were shipped on ice to the University of Idaho (Moscow, ID) and were kept frozen at –20 °C until their subsequent analysis.

Fatty acid analyses
Milk lipid samples were thawed at room temperature, and a 2-g mass was extracted by using chloroform and methanol in a 2-to-1 ratio (29). The extracted lipid was converted to FA methyl esters (FAMEs) by using a base-catalyzed transesterification method (30). The FAMEs in hexane were analyzed on a gas chromatograph (Hewlett-Packard 6890 Series with auto injector; Agilent, Palo Alto, CA) that was fitted with a flame ionization detector and a 100 m x 0.25 mm (0.2-µm film) capillary column coated with CP-Sil 88 (Chrompack; Middelburg, Netherlands). The initial oven temperature was 70 °C, which was held for 3 min, and then it was increased to 175 °C at a rate of 3 °C/min and held for 3 min. Next, the oven temperature was increased to 185 °C at a rate of 1 °C/min and held for 20 min, increased to 215 °C at a rate of 3 °C/min (with no hold), and, finally, increased to 230 °C at a rate of 10 °C/min and held for 5 min. Peaks were identified by comparison with known FA standards. Response correction factors determined by the analysis of a butter-oil standard with certified values (CRM 164; European Community Bureau of Reference, Brussels, Belgium) were used to convert FA peak area percentage to percentage by weight.

The FAME samples (0.1 mg) were separated into saturated, monoene, and diene FA fractions (31). Dimethyl disulfide adducts were prepared from the monoene FAME fraction (32). To ascertain the occurrence of specific 18:1 t-isomers, samples were analyzed by gas chromatography (GC)–mass spectrometry (MS) [Hewlett-Packard (HP) 6890 equipped with a DB-225ms capillary column; Agilent]. An HP series II 5973 quadrupole MS controlled by HP MS CHEMSTATION software (PC version D.01.00; Agilent) was used for MS analysis. Column temperature was programmed to increase from 195 °C to 230 °C at a rate of 0.5 °C/min during a total run time of 70 min. The peak areas of 18:1t isomers that were eluted with cis isomer peaks were calculated by standardizing the peak areas identified on the GC-MS of the dimethyl disulfide derivatives with the 18:1{Delta}11t peak. These methods are newly applied to human milk FA analysis; however, we previously used the same methods to examine 18:1t isomers in rumen bacterial cultures (32).

Statistical analysis
Correlations between the percentage by weight of each FA, total trans FAs, groups of similar FAs, and milk fat concentration were examined by using Pearson correlation coefficients generated by the PROC CORR procedure of SAS (version 8.02; SAS Institute, Cary, NC). Analysis of variance (PROC GLM) was used to ascertain the relations between total trans FAs and FA percentages. Milk samples were categorized as having high, medium, or low concentrations of trans FAs on the basis of naturally occurring breaks in the data when plotted by total concentrations of trans FAs. Group least-squares means for each FA were analyzed for differences by using the Tukey procedure. Relations were declared significant at P ≤ 0.05.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Fatty acid concentrations
Overall, 83 FA peaks were identified, and the concentrations of 12 FAs were found to be > 1% by weight of the total FAs. The 3 major FAs were palmitic (16:0; 20.8%), oleic (18:1{Delta}9c; 29.4%), and linoleic (18:2n–6; 12.7%) acid (Table 1Go). The major FA groups (Table 2Go) were the saturated FAs (40.6%), of which 51.1% was palmitic acid, and the monounsaturated FAs (42.4%) of which 69.3% was oleic acid. Linoleic acid made up 74.6% of the PUFAs. The 18:2{Delta}9c11t isomer made up 83.3% of the total CLA isomers (Table 1Go). The mean total trans FA concentration was 7.0 ± 2.3% [range: 2.5–13.8% (Table 2Go)]. The 18:1t isomers appeared to be normally distributed, and {Delta}9–12t were the most abundant isomers (Figure 1Go). Milk fat content (Table 2Go) as measured by using the creamatocrit method was similar to other published data (1).


View this table:
[in this window]
[in a new window]
  		TABLE 1 Concentration of major fatty acids (FAs) in human milk samples1

 

View this table:
[in this window]
[in a new window]
  		TABLE 2 Summary of selected fatty acids (FAs) and total fat of human milk1

 


View larger version (9K):
[in this window]
[in a new window]
  		FIGURE 1. Mean (±SD) distribution of individual trans 18:1 isomers as a percentage of total trans 18:1 isomers (18:1t) in human milk (n = 81).

 
Correlations among total fat, fatty acids, and fatty acid classes
For simplicity, only correlation comparisons for selected major FAs and FA groups are presented (Table 3Go). All correlations discussed here were significant (P < 0.05), unless otherwise stated. No correlations were observed between individual or total trans FAs and milk fat concentrations. Total 18:1t and total trans FAs were positively correlated with total CLA. No correlations were detected between linoleic acid, linolenic acid (18:3n–3), total n–3, or total n–6 FAs and total 18:1t or total trans FAs. However, total 18:1t was positively correlated with stearic acid (18:0) but negatively correlated with oleic acid. Total 18:1t, total trans FAs, and 18:2{Delta}10t12c (r = –0.384) were also negatively correlated with total {Delta}9-desaturase enzyme products (ie, the sum of 14:1{Delta}9c, 16:1{Delta}9c, 18:1{Delta}9c, and 18:2{Delta}9c11t).


View this table:
[in this window]
[in a new window]
  		TABLE 3 Pearson correlation coefficients for relations between selected major fatty acids (FAs) and FA groups in human milk1

 
On the basis of the wide variation in the total trans FA concentrations of these milk samples, the samples were grouped into 3 categories to evaluate the differences between the groups: high (samples containing ≥ 8% total trans FAs; n = 21), medium (samples containing > 5% but < 8% total trans FAs; n = 48), and low (samples containing ≤ 5% total trans FAs; n = 12) trans FAs (Table 4Go). The grouping of the data was based on naturally occurring breaks in the data when plotted by total content of trans FAs. For simplicity, only data for major individual FAs and FA groups are shown. For stearic and linoleic acid concentrations, there were no significant differences between groups. Total saturated FA and PUFA concentrations did not differ significantly between the groups; however, monounsaturated FA concentrations were higher in the high trans FA group than in the low trans FA group (P < 0.05).


View this table:
[in this window]
[in a new window]
  		TABLE 4 Comparison of composition of major fatty acids (FAs) and FA groups in human milk with different contents of trans FAs1

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The current study used modern analytic methods to comprehensively establish the FA profiles of milk samples from US women. Wolff et al (33) detailed concerns about the accuracy of the data from earlier studies. The current study used a combination of GC and GC-MS analyses to identify specific 18:1t isomers. These techniques allowed for the identification of a wide range of total trans FAs (Table 1Go) and individual 18:1t isomers (Figure 1Go) in human milk fat. Previous studies (17-26) evaluated the total trans FA concentrations in milk from women. Several of these studies are summarized in Table 5Go. The current survey of milk samples provides information concerning the FA composition of milk during early lactation by US women living in Arizona. The total concentration reported is not as variable as that in milk from Canadian women (17). However, the mean concentrations in milk from women from Arizona and Canada were not significantly different. In a comparison with the data presented here, data from the Czech Republic (21) and Germany (18, 26) showed that milk from women in those countries contained intermediate amounts of total trans FAs, whereas milk from women in Nigeria (19) and China (20) contained lower amounts. The consumption of foods that contain greater concentrations of trans FAs, such as processed foods made with partially hydrogenated vegetable oils and ruminant fat (35), leads to greater intakes of total trans FAs, which are incorporated into milk fat (3, 5, 22). These differences in the means and ranges of total trans FAs between milk from women in different countries may be partially attributed to differences in the diets consumed by the women in these various areas of the world (5, 33). It will be interesting to see whether current efforts to decrease trans FA consumption in the United States will lead to a lowering of milk trans FA concentrations in US women.


View this table:
[in this window]
[in a new window]
  		TABLE 5 Comparison of total trans fatty acids (FA) concentrations in human milk lipids of subjects in various countries1

 
Studies using similar techniques identified {Delta}10t and {Delta}11t as major 18:1t isomers (17, 18, 33, 36). Unfortunately, there has been little research on the dietary source of isomeric 18:1t, and patterns of 18:1t differ among foods (33, 35). All of the identified 18:1t isomers are typically found in both partially hydrogenated vegetable oils and ruminant fats. The {Delta}11t is the predominant 18:1t in ruminant fat (milk and beef), whereas {Delta}9t, {Delta}10t, and {Delta}11t predominate, and {Delta}12t is greater in partially hydrogenated vegetable sources (33, 35). The strong correlations among {Delta}9t, {Delta}10t, and {Delta}11t suggest that partially hydrogenated vegetable oils were the main dietary source of 18:1t for these lactating women. However, no reliable database of the isomeric 18:1t contents of foods exists from which this could be confirmed if dietary records were available. Thus, further investigation is needed.

As a result of the Institute of Medicine's call for the dietary intake of trans FAs to be as low as possible (15), new food-labeling laws have been adopted that require the labeling of the trans FA content of foods (16). If the food product contains > 0.5 g total trans FA per serving, not including CLA isomers, then the trans FA content of the food must be noted on the packaging. However, if the total is < 0.5 g per serving, then the product can be labeled as containing 0 g trans FAs. On the basis of these requirements and assuming that a single "serving" of human milk is 125 g, approximately one-half of the milk that we analyzed would require labeling. Nonetheless, whereas it would unquestionably be beneficial for breastfeeding mothers to decrease their consumption of high trans FA foods, human milk provides optimal nutrition for infants.

The concerns about trans FAs in the human diet have arisen because of the negative effect that trans FAs may have on heart health (37). Specifically, dietary supplementation with 7% total trans FAs and 5.5% 18:1{Delta}9t, a major trans FA formed during hydrogenation of plant oils (35), increased total and LDL cholesterol and decreased HDL cholesterol more than did diets rich in oleic, palmitic, or lauric and myristic acids (38). Furthermore, the treatment of linolelaidic acid (18:2{Delta}tt) in human hepatoma HepG2 cells resulted in an LDL:HDL of 1.18, as compared with ratios of 0.70 and 0.96 for linoleic and palmitic acid treatments, respectively (39).

In some studies, trans FAs have been shown to alter the incorporation of essential long-chain PUFAs into milk fat (40). When rats were provided diets containing different amounts of trans FAs but the same proportions of linoleic and linolenic acids, trans FAs were incorporated into milk fat in a dose-dependent manner. However, rats receiving dietary trans FAs had higher concentrations of linoleic acid in milk fat, but total long-chain PUFAs did not differ significantly between groups (40). In contrast, Innis and King (41) found an inverse relation between essential all-cis n–6 and n–3 FAs and total trans FAs in human milk. A similar inverse relation between total 18:1t and linoleic or linolenic acids was noted in Canadian milk samples (17). However, in the current study, no correlation between total trans FAs or total 18:1t and linoleic, linolenic, total n–3, or total n–6 FA was detected.

Individual isomers of trans FAs may have quite different effects on lipid metabolism. For example, Mahfouz et al (42) showed that 18:1{Delta}10t inhibited {Delta}9-desaturase activity in rat liver microsomes, whereas 18:1{Delta}9t had little effect, and 18:1{Delta}11t had an intermediate effect. Dietary 18:2{Delta}10t12c reduced mRNA expression of the {Delta}9-desaturase enzyme in mammary explants from lactating dairy cows (43). Hence, trans FAs may have negative effects on the concentration of oleic acid and other {Delta}9-desaturase products found in human milk, which could lead to lower consumption of oleic acid, an antiatherogenic FA (44), by infants. In support of these observations, total trans FAs, 18:1t, and 18:2{Delta}10t12c (data not shown) were negatively correlated with oleic acid and total {Delta}9-desaturase products (Table 3Go).

Our current study found no correlation between total trans FAs, 18:2{Delta}10t12c, or any other individual trans FA and milk fat concentration, which is similar to results obtained in an the analysis of Canadian human milk samples (17). However, when women received an experimental treatment of 1.5 g CLA supplement containing {approx}37% of the 18:2{Delta}10t12c isomer, a decrease in milk fat occurred (11). One difference noted between these studies was that the percentage by weight of 18:2{Delta}10t12c in the US milk samples was only 0.01% of total FAs, whereas that in the study by Masters et al (11) was >10-fold. Furthermore, the study of Masters et al was specifically designed to evaluate the decrease in milk fat induced by 18:2{Delta}10t12c interventions in a crossover experiment, whereas the current study was an evaluation of milk samples taken at the convenience of the subjects. These differences in experimental design and concentration of 18:2{Delta}10t12c may explain why no relation was identified between milk fat and 18:2{Delta}10t12c or total trans FAs.

This study shows that the concentrations of trans FAs in the human milk samples from Arizona are some of the highest reported in the United States and other countries. More regional information is needed to fully describe the variation in the concentrations of trans FAs in human milk samples throughout the United States. The effect of trans FAs on human health is an important area of research. Identifying the concentrations of trans FAs in human milk fat will aid in identifying possible relations between trans FAs and infant growth and health.


   ACKNOWLEDGMENTS
 
ALW was the principal investigator of the parent study and provided the samples for this study. MAM and MKM obtained funding for the analysis of the samples. EEM analyzed the data and wrote the manuscript, with input from all authors. None of the authors had any financial or personal interest in any organization sponsoring the research, including advisory board affiliations, or any other personal or financial conflict of interest.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Jensen RG, Bitman J, Carlson SE, Couch SC, Hamosh M, Newburg DS. Milk lipids A. Human milk lipids. In: Jensen RG, ed. Handbook of milk composition. San Diego: Academic Press, 1995:495–575.
  2. Neville MC, Picciano MF. Regulation of milk lipid secretion and composition. Annu Rev Nutr 1997;17:159–84.[Medline]
  3. Insull W Jr, Hirsch J, James T, Ahrens EH Jr. The fatty acids of human milk. II. Alterations produced by manipulation of caloric balance and exchange of dietary fats. J Clin Invest 1959;38:443–50.
  4. Chappell JE, Clandinin MT, Kearney-Volpe C. Trans fatty acids in human milk lipids: influence of maternal diet and weight loss. Am J Clin Nutr 1985;42:49–56.[Abstract/Free Full Text]
  5. Craig-Schmidt MC, Weete JD, Faircloth SA, Wickwire MA, Livant EJ. The effect of hydrogenated fat in the diet of nursing mothers on lipid composition and prostaglandin content of human milk. Am J Clin Nutr 1984;39:778–86.[Abstract/Free Full Text]
  6. Katan MB, Zock PL, Mensink RP. Trans fatty acids and their effects on lipoproteins in humans. Annu Rev Nutr 1995;15:473–93.[Medline]
  7. Genest J. Lipoprotein disorders and cardiovascular risk. J Inherit Metab Dis 2003;26:267–87.[Medline]
  8. Kummerow FA, Zhou Q, Mahfouz MM, Smiricky MR, Grieshop CM, Schaeffer DJ. Trans fatty acids in hydrogenated fat inhibited the synthesis of the polyunsaturated fatty acids in the phospholipid of arterial cells. Life Sci 2004;74:2707–23.[Medline]
  9. Koletzko B. Trans fatty acids may impair biosynthesis of long-chain polyunsaturates and growth in man. Acta Paediatr 1992;81:302–6.[Medline]
  10. Craig-Schmidt MC. Isomeric fatty acids: evaluating status and implications for maternal and child health. Lipids 2001;36:997–1006.[Medline]
  11. Masters N, McGuire MA, Beerman KA, Dasgupta N, McGuire MK. Maternal supplementation with CLA decreases milk fat in humans. Lipids 2002;37:133–8.[Medline]
  12. Teter BB, Sampugna J, Keeney M. Milk fat depression in C57Bl/6J mice consuming partially hydrogenated fat. J Nutr 1990;120:818–24.
  13. Bauman DE, Griinari JM. Regulation and nutritional manipulation of milk fat. Low-fat milk syndrome. Adv Exp Med Biol 2000;480:209–16.[Medline]
  14. Baumgard LH, Corl BA, Dwyer DA, Saebo A, Bauman DE. Identification of the conjugated linoleic acid isomer that inhibits milk fat synthesis. Am J Physiol 2000;278:R179–84.
  15. Institute of Medicine. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington DC: National Academies Press, 2002.
  16. Food labeling; trans fatty acids in nutrition labeling. Fed Regist 2003;68:41434–506.
  17. Chen ZY, Pelletier G, Hollywood R, Ratnayake WM. Trans fatty acid isomers in Canadian human milk. Lipids 1995;30:15–21.[Medline]
  18. Precht D, Molkentin J. C18:1, C18:2 and C18:3 trans and cis fatty acid isomers including conjugated cis {Delta}9, trans {Delta}11 linoleic acid (CLA) as well as total fat composition of German human milk lipids. Nahrung 1999;43:233–44.[Medline]
  19. Koletzko B, Thiel I, Abiodun PO. Fatty acid composition of mature human milk in Nigeria. Z Ernahrungswiss 1991;30:289–97.[Medline]
  20. Chen ZY, Kwan KY, Tong KK, Ratnayake WM, Li HQ, Leung SS. Breast milk fatty acid composition: a comparative study between Hong Kong and Chongqing Chinese. Lipids 1997;32:1061–7.[Medline]
  21. Dlouhy P, Tvrzicka E, Stankova B, et al. Trans fatty acids in subcutaneous fat of pregnant women and in human milk in the Czech Republic. Ann N Y Acad Sci 2002;967:544–7.[Abstract/Free Full Text]
  22. Aitchison JM, Dunkley WL, Canolty NL, Smith LM. Influence of diet on trans fatty acids in human milk. Am J Clin Nutr 1977;30:2006–15.[Abstract/Free Full Text]
  23. Picciano MF, Perkins EG. Identification of the trans isomers of octadecenoic acid in human milk. Lipids 1977;12:407–8.[Medline]
  24. Clark RM, Ferris AM, Fey N, Hundrieser KE, Jensen RG. The identity of the cholesteryl esters in human milk. Lipids 1980;15:972–4.
  25. Hundrieser KE, Clark RM, Brown PB. Distribution of trans-octadecenoic acid in the major glycerolipids of human milk. J Pediatr Gastroenterol Nutr 1983;2:635–9.[Medline]
  26. Koletzko B, Mrotzek M, Bremer HJ. Fatty acid composition of mature human milk in Germany. Am J Clin Nutr 1988;47:954–9.[Abstract/Free Full Text]
  27. Oddy WH, Halonen M, Martinez FD, et al. TGF-beta in human milk is associated with wheeze in infancy. J Allergy Clin Immunol 2003;112:723–8.[Medline]
  28. Lucas A, Gibbs JA, Lyster RL, Baum JD. Creamatocrit: simple clinical technique for estimating fat concentration and energy value of human milk. Br Med J 1978;1:1018–20.
  29. Clark RM, Ferris AM, Fey M, Brown PB, Hundrieser KE, Jensen RG. Changes in the lipids of human milk from 2 to 16 weeks postpartum. J Pediatr Gastroenterol Nutr 1982;1:311–5.[Medline]
  30. Christie WW. A simple procedure for rapid transmethylation of glycerolipids and cholesteryl esters. J Lipid Res 1982;23:1072–5.[Abstract]
  31. Christie WW. Silver ion chromatography using solid-phase extraction columns packed with a bonded-sulfonic acid phase. J Lipid Res 1989;30:1471–3.[Abstract]
  32. Mosley EE, Powell GL, Riley MB, Jenkins TC. Microbial biohydrogenation of oleic acid to trans isomers in vitro. J Lipid Res 2002;43:290–6.[Abstract/Free Full Text]
  33. Wolff RL, Precht D, Molkentin J. Trans-18:1 acid content and profile in human milk lipids. Critical survey of data in connection with analytical methods. J Am Oil Chemists Soc 1998;75:661–71.
  34. Boatella J, Rafecas M, Codony R, et al. Trans fatty acid content of human milk in Spain. J Pediatr Gastroenterol Nutr 1993;16:432–4.[Medline]
  35. Innis SM, Green TJ, Halsey TK. Variability in the trans fatty acid content of foods within a food category: implications for estimation of dietary trans fatty acid intakes. J Am Coll Nutr 1999;18:255–60.[Abstract/Free Full Text]
  36. Chardigny JM, Wolff RL, Mager E, Sebedio JL, Martine L, Juaneda P. Trans mono- and polyunsaturated fatty acids in human milk. Eur J Clin Nutr 1995;49:523–31.[Medline]
  37. Ascherio A. Epidemiologic studies on dietary fats and coronary heart disease. Am J Med 2002;113(suppl):9S–12S.
  38. Sundram K, Ismail A, Hayes KC, Jeyamalar R, Pathmanathan R. Trans (elaidic) fatty acids adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans. J Nutr 1997;127:514S–20S.
  39. Dashti N, Feng Q, Freeman MR, Gandhi M, Franklin FA. Trans polyunsaturated fatty acids have more adverse effects than saturated fatty acids on the concentration and composition of lipoproteins secreted by human hepatoma HepG2 cells. J Nutr 2002;132:2651–9.[Abstract/Free Full Text]
  40. Larque E, Zamora S, Gil A. Dietary trans fatty acids affect the essential fatty-acid concentration of rat milk. J Nutr 2000;130:847–51.[Abstract/Free Full Text]
  41. Innis SM, King DJ. Trans fatty acids in human milk are inversely associated with concentrations of essential all-cis n–6 and n–3 fatty acids and determine trans, but not n–6 and n–3, fatty acids in plasma lipids of breast-fed infants. Am J Clin Nutr 1999;70:383–90.[Abstract/Free Full Text]
  42. Mahfouz MM, Johnson S, Holman RT. The effect of isomeric trans-18:1 acids on the desaturation of palmitic, linoleic and eicosa-8,11,14-trienoic acids by rat liver microsomes. Lipids 1980;15:100–7.[Medline]
  43. Baumgard LH, Matitashvili E, Corl BA, Dwyer DA, Bauman DE. Trans-10, cis-12 conjugated linoleic acid decreases lipogenic rates and expression of genes involved in milk lipid synthesis in dairy cows. J Dairy Sci 2002;85:2155–63.[Abstract/Free Full Text]
  44. Molkentin J. Occurrence and biochemical characteristics of natural bioactive substances in bovine milk lipids. Br J Nutr 2000;84(suppl):S47–53.
Received for publication May 18, 2005. Accepted for publication August 29, 2005.




This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
E. Szabo, G. Boehm, C. Beermann, M. Weyermann, H. Brenner, D. Rothenbacher, and T. Decsi
trans Octadecenoic acid and trans octadecadienoic acid are inversely related to long-chain polyunsaturates in human milk: results of a large birth cohort study
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1320 - 1326.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. Friesen and S. M. Innis
Trans Fatty Acids in Human Milk in Canada Declined with the Introduction of Trans Fat Food Labeling
J. Nutr., October 1, 2006; 136(10): 2558 - 2561.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
E. E. Mosley, M. K. McGuire, J. E. Williams, and M. A. McGuire
Cis-9, Trans-11 Conjugated Linoleic Acid Is Synthesized from Vaccenic Acid in Lactating Women
J. Nutr., September 1, 2006; 136(9): 2297 - 2301.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mosley, E. E
Right arrow Articles by McGuire, M. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mosley, E. E
Right arrow Articles by McGuire, M. A
Agricola
Right arrow Articles by Mosley, E. E
Right arrow Articles by McGuire, M. A

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS